2nd Annual Digi-Tech Pharma 2018

2nd Annual Digi-Tech Pharma is organized by Corvus Global Events (CGE) and will be held during May 02 - 03, 2018 at London, England, United Kingdom.

The target audience for this medical event is senior level attendees from various companies including pharmaceutical, biotechnological, biopharmaceutical, CRO’s, Diagnostics, solution provider and government institutions.

Course Description:
Emerging technologies are changing the landscape of Pharmaceutical industry and their relationship with their customers while creating new opportunities for collaboration. Pharma companies have to think beyond the pill and substantiate the value of their drugs in the real world, which would lead to a better patient outcome. Thus a necessity for partnership and collaboration with the healthcare provider is a must for pharmaceutical companies to be ahead of the game and make most use of the healthcare technologies, resources and tools that integrate with patient’s lifestyle which could definitely compliment the strengths of both pharma and healthcare.

The deployment of technology is now increasingly dominant in pharmaceutical R&D; the enhancements in data management and data integration are providing improvements to both the speed and quality of many clinical trial processes. The digital sensors connected to the Internet of Healthcare Things (IoHT) that is generating vast amount of Big Data is drawing the attention of pharmaceutical firms and moreover the Patient data is extremely valuable to drug companies as the analytics technology can be used to explore Big Data to reveal connections and patterns that allow the evolution of precision medication. Artificial intelligence has been a disruptive technological force in healthcare as a whole, but it is proving to have massive benefits in pharmaceuticals and drug discovery. The combination of AI, big data and IoT technologies will create new innovations and other eminent technologies like cloud computing, augmented reality, virtual reality, 3D printing and blockchain are being used extensively in the Pharmaceutical industry’s digital transformation.

Therefore this upcoming conference 2nd Annual Digi-Tech Pharma 2018, will provide a platform to all its participants an opportunity to interact, share and discuss the digitalization of Pharma industry. The conference will allow its participants to discuss the various challenges faced, new strategies, case studies and use of innovative ideas in the field of Digital Pharma IT. Also, to stay updated on the latest trends in digital, social media and mobile strategies required to overcome the obstructions in the transformation. This Digi-Tech Pharma 2018 is a unique platform in the Pharmaceutical Conferences which will allow IT leaders to share their technologies and strategies to help the pharma industries avail new opportunities to encourage partnerships and collaborations.

It gives us a great pleasure to welcoming you to this international 2nd Annual Digi-Tech Pharma 2018 conference.

Key Highlights
• The global technology outlook and its impact on pharma industry
• How pharma can integrate into digital health environment
• Big data analytics and pharma
• Internet of things and pharma
• Policy changes required for ensuring smooth transition
• Ensuring regulatory compliance during the transformation
• Streamlining and digitizing research workflows
• Clinical trials and digital world
• Digitally transformed pharmacovigilance
• Data management
• 3D printing technology in pharmaceutical drug delivery
• Tools and strategies to engage with HCPs
• Encouraging a customer–centric approach at all levels
• Digitally enabled business models
• Develop partnerships to support the deployment of digital technology
• Digital marketing trends
• Integrating Multichannel marketing and closed loop marketing
• Translational informatics
• Precision Medicine and genomics
• AI & Machine learning is transforming drug discovery
• Blockchain technology to improve efficiency and safety
• Model for Future Digital Innovation

Key Speakers:
• Dirk Voelkel, Chief Technology Officer - Innovation and Analytics, GE Healthcare Life Science
• Bert Hartog, R&D Operations - Innovation Leader , Janssen Pharmaceutical Companies of Johnson & Johnson
• Tim Cave, VP - Head Strategic Planning and Digital Practices, Global Medical Affairs, GlaxoSmithKline
• Pol Mac Aonghusa, Senior Research Manager, IBM Research (Former CTO, Emerging Technology Centre, IBM)
• Joanne M. Hackett, Chief Commercial Officer, Genomics England
• Mats Sundgren, Director Health Informatics, AstraZeneca
• Karen Akinsanya, President, Envision Science Group (Former AVP, Research Insights & Analytics, Merck)
• Elena Bonfiglioli Senior Director Health and Life Sciences, Europe Middle East Africa (EMEA), Microsoft
• Andrea Splendiani, Associate Director, Information Systems, Novartis
• Magdalena Schoeneich, Global Head of Takeda Digital Accelerator, R&D, Takeda
• Lun Yang, Deputy Director, Drug Discovery, Bayer
• Peter Hamley, Global Head, External Innovation, Drug Discovery Platforms, Sanofi
• Jenny Royle, Patient-centricity senior program leader, Digital Experimental Cancer Medicines Team, Cancer
• Research UK Manchester Institute and The Christie NHS Foundation Trust
• Pelin Icil, Marketing Manager & Cluster Marketing Lead, Bayer

Additional details will be posted as soon as they are available.